Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 32.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an important determinant of neonatal morbidity and should be considered as a surrogate for nutritional status in neonates. In addition, low birth weight is not a reliable indicator of malnutrition in all neonates. Further studies are required to establish whether BF% can be used to identify undernourished neonates. This would provide an alternative method to identifying those at high risk of morbidity. Furthermore, these findings could inform strategies to improve the nutritional status of pregnant women and their offspring. Copyright © 2016 John Wiley & Sons, Ltd.
[/INST]],

Keywords:
Body fat percentage, neonatal morbidity, birth weight, nutritional status, undernutrition.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The response is partially correct but incomplete. It correctly notes that low BF% is associated with neonatal morbidity and that birth weight alone can miss undernourished infants. However, it fails to state explicitly that, in this study, BF% was more closely associated with neonatal morbidity than birth weight percentiles (the BF% effect size/OR was substantially larger), and it does not report the comparative findings or prevalence numbers that support that conclusion. The answer also includes an irrelevant copyright line and uses somewhat stronger language ("surrogate") without fully acknowledging study limitations. A clearer, more precise summary citing the comparative results and limitations would be better.

conciseness: 0.6
Reasoning:
The response is brief and addresses the question by saying low BF% is an important indicator and that birth weight percentile is not fully reliable. However it is somewhat indirect and repetitive, adds hedging about needing further studies without citing the study's stronger result, and includes an irrelevant copyright line. It could be more concise and more directly state that BF% better identifies neonates at risk based on the presented findings.

relevance: 0.7
Reasoning:
The assistant's reply is relevant and answers the question: it states that low BF% is a meaningful indicator of neonatal undernutrition and that birth weight alone can miss malnourished infants, which matches the study's conclusion. However, it does not quote or cite the specific data or language from the context (no ORs or quantified comparison), offers an arguably unnecessary caution about needing further studies despite strong reported associations, and includes an extraneous copyright line. Overall the response is concise and directionally correct but could be improved by explicitly referencing the study's comparative findings and statistics.

coherence: 0.6
Reasoning:
The response is moderately coherent: it directly answers the question by stating that low BF% is an important indicator of neonatal nutritional status and that birth weight is not always reliable, and it notes the need for further study. However, it is incomplete and somewhat inconsistent with the study details: it does not summarize the comparative strength of association (e.g., the reported stronger OR for BF%), does not quantify how many neonates were identified by BF% versus birth weight percentiles, and contains an irrelevant copyright line. The conclusion that BF% "should be considered" is reasonable, but the answer could be clearer about the evidence and limitations.

helpfulness: 0.6
Reasoning:
The assistant's reply summarizes the main conclusion (BF% is more informative than birth weight percentiles) and correctly cautions that further research is needed. However it is brief and lacking important details from the study (no mention of the comparative effect sizes, prevalence, or the key point that BF% can identify appropriately grown but undernourished neonates and exclude small neonates not at risk). It also includes an irrelevant copyright line and slightly overstates BF% as a "surrogate" without presenting supporting numbers. Overall, the response is directionally correct and somewhat helpful but incomplete and lightly imprecise.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The results of this study show that the presence of ischemic Charcot neuroarthropathy in association with critical limb ischemia represents a complex pathology, where the treatment must include both vascular and orthopedic intervention. This is essential to achieve an adequate limb salvage rate and to prevent further progression of the disease. Our results suggest that a multidisciplinary approach should be adopted in these cases. Further studies are needed to better define the natural history of this condition and to establish its role as a separate entity from other forms of Charcot neuroarthropathy. Furthermore, it seems to be important to use early diagnostic imaging modalities such as ultrasonography to identify the underlying cause of the disease. Finally, it is necessary to consider the possibility of a delayed diagnosis due to the difficulty of recognizing the clinical features of the disease, which could lead to a worse outcome. Therefore, we recommend that these patients receive careful observation and early aggressive treatment. The authors have no conflicts of interest or financial disclosures related to this work. To our knowledge, this is the first study to analyze the results of endovascular and surgical treatment in patients affected by ischemic Charcot neuroarthropathy and critical limb ischemia. Future prospective studies will help to confirm the efficacy of this approach. Copyright © 2013 ISMP and European Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.8
Reasoning:
The assistant’s reply correctly emphasizes that ischemic Charcot neuroarthropathy is a complex condition requiring both vascular and orthopedic management and that a multidisciplinary approach (including revascularization to support surgical/orthopedic treatment) improves limb-salvage—this aligns with the ground truth. It also appropriately warns about diagnostic delays and the need for early, aggressive care. Weaknesses: it never explicitly answers “yes/no” to whether ischemic Charcot is a distinct entity, makes a somewhat imprecise recommendation of ultrasonography as the key early diagnostic modality for ischemia (angiography/Doppler/CTA are typically used to define arterial disease and plan revascularization), and includes unnecessary publication/copyright text. Overall the content is accurate and clinically relevant but could be clearer and more precise.

conciseness: 0.3
Reasoning:
The response communicates the main idea (that ischemic Charcot requires both vascular and orthopedic treatment and a multidisciplinary approach) but is not concise: it repeats points, includes irrelevant publication/copyright statements and speculative or extraneous details (e.g., ultrasonography, conflicts of interest, first-study claim) that do not directly answer the question. It could be much shorter and more focused.

relevance: 0.7
Reasoning:
The assistant's reply is largely relevant: it correctly states that ischemic Charcot neuroarthropathy requires both vascular (revascularization) and orthopedic/surgical interventions and that a multidisciplinary approach can improve limb salvage — which matches the study's main finding. However, the answer adds details not supported by the provided context (specific recommendation of ultrasonography, emphasis on delayed diagnosis as a new point, and the claim about being the "first study") and does not cite the study's reported outcomes (90% limb salvage, mean healing time ~197 days). Overall it answers the question but includes some unsupported or extraneous assertions and omits key reported results.

coherence: 0.7
Reasoning:
The response is generally coherent and organized: it summarizes the study findings, recommends a multidisciplinary (vascular + orthopedic) approach, and highlights the need for further research. It conveys the practical implication that ischemic Charcot neuroarthropathy requires combined revascularization and orthopedic care to improve limb salvage, which addresses the question. Weaknesses: it never explicitly answers “yes” or “no” to whether ischemic Charcot is a distinct disease entity, includes some unnecessary/admin text (copyright/conflict statement) and a speculative imaging recommendation (ultrasonography) without justification, and is somewhat repetitive. Overall it reads reasonably well but could be clearer and more concise.

helpfulness: 0.8
Reasoning:
The assistant's reply correctly concludes that ischemic Charcot foot is a complex condition requiring both vascular (revascularization/vascular intervention) and orthopedic/surgical management and that a multidisciplinary, early and aggressive approach improves limb salvage—which aligns with the ground truth. It is helpful in emphasizing combined vascular+orthopedic treatment and the need for close monitoring. Shortcomings: it is somewhat vague (doesn't explicitly state "revascularization" as the needed vascular therapy or give the reported limb-salvage/healing outcomes), and its recommendation of ultrasonography as an early imaging modality is oversimplified (arterial duplex, CT/contrast angiography or catheter angiography are often required to plan revascularization). Overall the answer is relevant and reasonably informative but lacks some specificity and detail.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Although RH may be beneficial for patients with advanced endometrial cancer with suspected gross cervical involvement, it did not improve outcomes compared to mRH or SH in this trial. Therefore, we could not recommend RH for all patients with endometrial cancer with suspected gross cervical involvement. Further investigation on the role of RH for endometrial cancer with suspected cervical involvement is warranted. Copyright © 2016 Japanese Society of Gynecologic Oncology. Published by John Wiley&Sons Ltd. Reprints and permissions: jsogo@jstage.or.jp. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To the extent possible under law, the authors have waived any moral rights associated with publication of this work. Funding: Ministry of Health, Labour and Welfare of Japan. Grant numbers: H28-Jisedai-Ichi-Ken-Ken-Kyouiku-Kentei-Bunseki-Koubou-Oyou-Koutou-Kyouiku-Kentei-Koubou-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunseki-Koubou-Kyouiku-Kentei-Bunse

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.5
Reasoning:
Short explanation: The assistant's answer correctly states the study's key conclusion that radical hysterectomy (RH) did not improve outcomes compared with modified radical or simple hysterectomy. However the reply is imprecise and incomplete: it begins with a contradictory phrase ("Although RH may be beneficial... it did not improve outcomes"), fails to report important findings about higher perioperative and late adverse events with RH (longer operative time, more transfusions, worse urinary dysfunction), omits the prognostic factors identified (age, grade, peritoneal cytology, lymph node status), and includes irrelevant/garbled copyright and funding text. These shortcomings reduce clarity and usefulness.

conciseness: 0.4
Reasoning:
The response states the main conclusion (no survival benefit of RH and that RH should not be routinely recommended) but is not concise: it contains a contradictory opening clause ("Although RH may be beneficial... it did not improve outcomes"), omits mention of the increased perioperative/late adverse events with RH and the other identified prognostic factors, and includes long irrelevant copyright/funding text. These issues make the answer unclear and verbose.

relevance: 0.5
Reasoning:
The response partially answers the question by stating that radical hysterectomy (RH) did not improve outcomes compared with modified or simple hysterectomy and that RH should not be universally recommended, which matches the study's main conclusion. However, it contains a contradictory phrase ("Although RH may be beneficial... it did not improve outcomes"), omits mention of the higher perioperative/late adverse events with RH and the finding that hysterectomy type was not an independent prognostic factor, and includes irrelevant/garbled copyright and funding text. Overall, relevant but flawed and noisy.

coherence: 0.3
Reasoning:
The response is only partially coherent. It states the trial found no outcome benefit for radical hysterectomy (consistent with the study) but immediately begins with a contradictory clause ("Although RH may be beneficial... it did not improve outcomes"), which creates confusion. The answer omits an important finding from the study (higher perioperative and late adverse events with RH) and includes extraneous, garbled copyright/funding text that is irrelevant to the clinical question. Overall it answers the question briefly but is poorly organized and contains contradictory and irrelevant content.

helpfulness: 0.3
Reasoning:
The response partially captures the study’s main conclusion (no clear survival benefit of radical hysterectomy and that RH should not be universally recommended), but it is imprecise and incomplete. It incorrectly hedges by saying RH “may be beneficial,” which contradicts the study finding of no outcome improvement, and it fails to report important trial details (that RH had longer operative time, higher transfusion rates, and more severe urinary dysfunction). The answer also includes irrelevant/corrupted copyright and funding text, reducing clarity and usefulness.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions following PD are associated with significant risk factors such as prolonged length of hospitalization, multivisceral resections, and ICU admissions. Improving these preoperative parameters may help reduce readmissions after PD. This will also help decrease the overall cost of care. Prospective studies are warranted to explore the use of prophylactic strategies to prevent or minimize readmissions after PD. The NSQIP registry is an excellent tool to monitor quality metrics and identify areas where improvement is possible. Future studies should focus on the development of evidence-based guidelines to improve patient outcomes and decrease health-care expenses after PD. Copyright © 2015 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved. KEYWORDS: Pancreaticoduodenectomy; Quality of care; Postoperative complications; Hospital readmissions; Pancreatic fistula; Multivisceral resection.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.4
Reasoning:
The assistant's reply correctly highlights some factors associated with readmission after PD (multivisceral resection, prolonged hospital stay, ICU admission) and appropriately calls for prospective work and registry use. However it omits a key independent predictor — pancreatic fistula — and fails to note that ~50% of readmissions occur within 7 days (so prevention efforts should target early readmissions). It also misleadingly frames length of stay and ICU admission as "preoperative parameters" when they are peri-/postoperative. Overall the response is incomplete and partly imprecise.

conciseness: 0.5
Reasoning:
The response is concise and mentions some relevant risk factors (multivisceral resection, prolonged stay, ICU admission) and general strategies (prospective studies, registries, guidelines). However it omits the key findings that pancreatic fistula and complexity of the initial resection were independent predictors of readmission, and it fails to note that half of readmissions occur early (≤7 days) — a central point implying prevention efforts should focus on early postdischarge care. It also ambiguously suggests improving "preoperative parameters" for problems that are largely intra- or postoperative and includes irrelevant publication boilerplate. 

relevance: 0.4
Reasoning:
Explanation: The response partially addresses the question by naming several factors (length of stay, multivisceral resection, ICU admission) that were identified in the study as associated with readmission, and it sensibly calls for prospective work and use of registries. However, it omits a key independently associated factor from the paper — pancreatic fistula — and fails to note that half of readmissions occur early (≤7 days) and that preventing early readmissions was highlighted as a priority. The answer also incorrectly frames some listed factors (length of stay, ICU admission) as "preoperative parameters," which is misleading. Overall the reply is only partially relevant and contains inaccuracies and important omissions.

coherence: 0.4
Reasoning:
The assistant's reply is moderately coherent and organized — it lists several risk factors (length of stay, multivisceral resection, ICU admission), recommends prospective studies and use of NSQIP, and calls for evidence-based guidelines. However it omits key findings from the study (notably that pancreatic fistula was an independent predictor of readmission) and fails to emphasize that half of readmissions occur early (≤7 days) and therefore prevention efforts should target early postdischarge complications. It also inaccurately refers to some mainly postoperative factors as "preoperative parameters" and includes an irrelevant copyright line. Overall the response is incomplete and partly imprecise.

helpfulness: 0.4
Reasoning:
Explanation: The assistant's reply correctly cites some factors associated with readmission (multivisceral resection, prolonged hospital stay, ICU admission) and appropriately calls for prospective work and use of registries like NSQIP. However it omits a key independent predictor reported in the ground truth—pancreatic fistula—and fails to note that half of readmissions occur within 7 days and that efforts should particularly target preventing early readmissions. The recommendations are generic (prophylactic strategies, evidence-based guidelines) and lack specific, actionable prevention measures tied to the study findings. The inclusion of copyright/keyword text is irrelevant to the user's question. Overall the response is partially helpful but incomplete and imprecise relative to the evidence presented.

================================================================================
Average correctness Score: 0.435
Average conciseness Score: 0.315
Average relevance Score: 0.42
Average coherence Score: 0.425
Average helpfulness Score: 0.41
